Table 2 Clinical and parasitological response by treatment group
| Â | ETF | LCF | LPF | ACPR* | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CQ %(N) | AQ %(N) | SP %(N) | CQ %(N) | AQ %(N) | SP %(N) | CQ %(N) | AQ %(N) | SP %(N) | CQ %(N) | AQ %(N) | SP %(N) | ||
14 Days | 2002 | 5.4 (5) | 0.0 (0) | 0.0 (0) | 7.6 (7) | 0.0 (0) | 0.0 (0) | 38.0 (35) | 5.7 (3) | 7.3 (4) | 48.9 (45) | 94.3 (50) | 92.7 (51) |
| Â | 2003 | 7.3 (8) | 5.5 (3) | 1.6 (1) | 3.6 (4) | 1.8 (1) | 0.0 (0) | 27.3 (30) | 7.3 (4) | 4.9 (3) | 61.8 (68) | 85.5 (47) | 93.4 (57) |
| Â | Total | 6.4 (13) | 2.8 (3) | 0.9 (1) | 5.4 (11) | 0.9 (1) | 0.0 (0) | 32.2 (65) | 6.5 (7) | 6.0 (7) | 55.9 (113) | 89.8 (97) | 93.1 (108) |
28 Days | 2002 | 5.4 (5) | 0.0 (0) | 0.0 (0) | 20.7 (19) | 1.9 (1) | 0.0 (0) | 59.8 (55) | 35.8 (19) | 11.1 (6) | 14.1 (13) | 62.3 (33) | 88.9 (48) |
| Â | 2003 | 7.3 (8) | 5.5 (3) | 1.6 (1) | 20.0 (22) | 5.5 (3) | 0.0 (0) | 54.5 (60) | 29.1 (16) | 13.1 (8) | 18.2 (20) | 60.0 (33) | 85.2 (52) |
| Â | Total | 6.4 (13) | 2.8 (3) | 0.9 (1) | 20.3 (41) | 3.7 (4) | 0.0 (0) | 56.9 (115) | 32.4 (35) | 12.2 (14) | 16.3 (33) | 61.1 (66) | 86.9 (100) |